News
Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure ...
6h
Money Talks News on MSNFDA Approves the First Blood Pressure Monitor You Can Wear on Your WristThe Hilo Band is worn on the wrist like a bracelet. It works by providing what’s known as optical blood pressure monitoring: ...
Aktiia, a pioneer in continuous blood pressure monitoring, has secured FDA 510(k) clearance for its medical-grade G0 Blood ...
Aktiia, a pioneer in optical blood pressure monitoring, announced today that it has received U.S. Food and Drug ...
The band can be worn during the day and night, allowing patients to track blood pressure patterns across a 24-hour cycle.
The FDA has cleared its first cuffless blood pressure monitor that will be available over-the-counter, with the Hilo ...
Explore more
Hosted on MSN9mon
Aktiia trained AI on 11 billion data points of blood pressure, and now a clinically certified app is coming - MSNAktiia claims its app can give users accurate blood pressure and heart rate measurements from the camera of a smartphone. Users place their fingertip on the camera, and in 90 seconds the software ...
Aktiia has CE Mark class IIa medical device approval, and to date over 55 million measurements have been taken across Europe making Aktiia's dataset the largest BP database ever recorded.
Aktiia (based out of Neuchatel, Switzerland, but with a U.S. operation) already specialized in blood pressure technology with a hardware sensor that sits at your wrist. However, it’s now ...
The Aktiia app would leverage something everyone has – a smartphone. And that makes it more powerful than even having blood pressure tracking on ubiquitous smartwatches such as the Apple Watch.
The FDA has given 510(k) clearance to health tech company Aktiia for over-the-counter use of its G0 Blood Pressure Monitoring system. According to the FDA website, the device received clearance July 2 ...
Neuchâtel, Switzerland-based Aktiia said its G0 Blood Pressure Monitoring System will be available in the U.S. in 2026.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results